Who owns Pabron?
Pabron is owned by Taisho Pharmaceutical (Japan).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Taisho Pharmaceutical: History, Taisho Pharmaceutical Co., Ltd. Last checked .
Key facts
- Current owner
- Taisho Pharmaceutical Holdings Co., Ltd. reported
- Owner HQ
- 🇯🇵 Japan, Tokyo
- Origin
- 🇯🇵 Japan
- Founded
- 1927
- Category
- Consumer health › Over-the-counter medicine › Cold
- Last verified
- · 1 sources
About Pabron
Cold remedy brand of Taisho Pharmaceutical. The first product named Pabron was released in 1927 as a cough suppressant made mainly from crude drug extract. The line today covers cold remedies, cough tablets and rhinitis products, and Taisho launched Pabron in Thailand in 2005 alongside its Taisho Kampo stomach medicine.
Ownership timeline of Pabron
- Current owner Taisho Pharmaceutical [1] reported
Where Pabron sits in Taisho Pharmaceutical
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Taisho Pharmaceutical ownership tree →
See the full Taisho Pharmaceutical brand portfolio (7) →
Other brands owned by Taisho Pharmaceutical
Taisho Pharmaceutical controls 7 brands on Brandtree, 6 of them in consumer health.
Also in consumer health
Other brands in cold, and who owns them
The 31 brands in cold on Brandtree belong to 18 owners. The largest is Krka, with 5.
| Brand | Owner | Owner based in |
|---|---|---|
| Herbion | Krka | 🇸🇮 Slovenia |
| Breathe Right | Prestige Consumer Healthcare | 🇺🇸 United States |
| Lemsip | Reckitt | 🇬🇧 United Kingdom |
| Dimestil | Birzeit Pharmaceutical | 🇵🇸 Palestine |
| HealthCareAisle | Dr. Reddy's | 🇮🇳 India |
| Tukol | Genomma Lab | 🇲🇽 Mexico |
| Benadryl | Kenvue | 🇺🇸 United States |
| Allergosan | Sopharma | 🇧🇬 Bulgaria |
About the owner: Taisho Pharmaceutical
Taisho Pharmaceutical is a privately held company headquartered in Tokyo, Japan, founded in 1912. Brandtree records 7 brands under its control.
Japanese pharmaceutical and over-the-counter health company, founded in 1912 and based in Toshima-ku, Tokyo. Its shares were delisted from the stock exchange on 9 April 2024, so it is now unlisted. Outside Japan it bought Bristol-Myers Squibb's Asian OTC trademarks in 2009 and took control of Vietnam's Duoc Hau Giang (DHG) and France's UPSA in 2019; Taisho also sells some brands in Japan under licence from other owners (for example Vicks and Claritin), which are not listed here.
Taisho Pharmaceutical: full profile, brands and acquisition history →
🇯🇵 Pabron and other Japanese brands
Brandtree records a controlling owner for 437 brands that began in Japan. 21 of them (5%) are now controlled by a company headquartered in another country; Pabron is not one of them.
- Air Salonpas — Hisamitsu Pharmaceutical 🇯🇵
- Ammeltz — Kobayashi Pharmaceutical 🇯🇵
- Daiichi Sankyo Stomach Medicine — Daiichi Sankyo Healthcare 🇯🇵
- Jelly Monster — Okamoto Industries 🇯🇵
- "K" Line — K Line 🇯🇵
- ABEMA — CyberAgent 🇯🇵
Frequently asked questions
Who is the parent company of Pabron?
The parent company of Pabron is Taisho Pharmaceutical, a privately held company headquartered in Japan.
Is Pabron Japanese?
Yes. Pabron originated in Japan in 1927 and its owner, Taisho Pharmaceutical, is also headquartered in Japan.
Is Pabron still owned by Taisho Pharmaceutical?
Yes. As of 4 October 2026, Pabron is still owned by Taisho Pharmaceutical. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Taisho Pharmaceutical: History — Taisho Pharmaceutical Co., Ltd., Official document; retrieved 4 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.